𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapies for bleomycin induced lung fibrosis through regulation of TGF-β1 induced collagen gene expression

✍ Scribed by Kenneth R. Cutroneo; Sheryl L. White; Sem H. Phan; H. Paul Ehrlich

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
186 KB
Volume
211
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

This review describes normal and abnormal wound healing, the latter characterized by excessive fibrosis and scarring, which for lung can result in morbidity and sometimes mortality. The cells, the extracellular matrix (ECM) proteins, and the growth factors regulating the synthesis, degradation, and deposition of the ECM proteins will be discussed. Therapeutics with particular emphasis given to gene therapies and their effects on specific signaling pathways are described. Bleomycin (BM), a potent antineoplastic antibiotic increases TGF‐β1 transcription, TGF‐β1 gene expression, and TGF‐β protein. Like TGF‐β1, BM acts through the same distal promoter cis‐element of the COL1A1 gene causing increased COL1 synthesis and lung fibrosis. Lung fibroblasts exist as subpopulations with one subset predominately responding to fibrogenic stimuli which could be a specific cell therapeutic target for the onset and development of pulmonary fibrosis. J. Cell. Physiol. 211: 585–589, 2007. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

TGF-β1-induced Smad 3 binding to the Sma
TGF-β1-induced Smad 3 binding to the Smad 7 gene: Knockout of Smad 7 gene transcription by sense phosphorothioate oligos, autoregulation, and effect on TGF-β1 secretion: Bleomycin acts through TGF-β1
✍ Kenneth R. Cutroneo; Sem H. Phan 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

## Abstract Bleomycin produces its fibrogenic effect, at least in part, by TGF‐β1 secretion. Treatment of IMR‐90 human embryonic lung fibroblasts with bleomycin at 0.5 μg/ml results in a 1.6‐fold increase of TGF‐β1 as determined by a specific ELISA assay for TGF‐β1 after acidification of the condit

TGF-β-induced expression of tissue inhib
TGF-β-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor
✍ Hamid Yaqoob Qureshi; Judith Sylvester; Mohammed El Mabrouk; Muhammad Zafarullah 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB

## Abstract Transforming growth factor (TGF‐β1) is a potent inducer of chondrogenesis and stimulant of cartilage extracellular matrix (ECM) synthesis. Tissue inhibitor of metalloproteinases‐3 (TIMP‐3) is located in ECM and is the major inhibitor of matrix metalloproteinases (MMPs) and aggrecanase,